The Most Powerful Career Combination in Global Pharma — Mastered in 4 Months
Become dual-certified in Drug Safety and Clinical Research. The professionals who understand both ICSR processing and clinical trial operations are the most in-demand, highest-paid individuals in the industry. Become one of them.
Seats are limited per batch. Early registration recommended.
Program Overview
The Advanced Dual Certification in Drug Safety & Clinical Research is the single most powerful career investment available to pharmaceutical professionals. By mastering both drug safety reporting operations and complete clinical trial ecosystems simultaneously, graduates become indispensable assets to CROs, pharma MNCs, biotech companies, and regulatory agencies worldwide.
Most professionals choose one path. This program gives you both — in a single, integrated 4-month curriculum designed so that each domain strengthens your understanding of the other. The dual-domain skill set is not just a differentiator. It is a career multiplier. It opens more roles, at higher levels, in more geographies than either certification alone.
Why Global Pharmacovigilance Academy?
PV and clinical research are taught as a connected system — because that is how they function in the real industry. Each domain deepens your understanding of the other.
14 weeks of structured content plus dedicated simulation and assessment weeks means genuine depth, not surface coverage.
Week 13 is a full simulation week — ICSR processing, SAE handling, and clinical safety scenarios run under near-real conditions with faculty review.
Graduates are qualified for PV roles, clinical research roles, AND the rare dual-domain positions that command the highest compensation in the sector.
Is This Program Right for You?
Week-by-Week Curriculum
Each week combines structured knowledge with practical, industry-aligned application.
- Drug lifecycle from IND to post-market surveillance
- Where clinical research ends and PV begins
- Key stakeholders in both domains and their interactions
- How PV and clinical data flow into the same systems
- ADRs, seriousness classification, and reporting sources
- Four valid case criteria applied across source types
- Triage logic, prioritisation, and intake workflows
- Data entry standards and completeness requirements
- GCP principles applied to real-world trial functions
- Sponsor, CRO, and investigator obligations
- Protocol deviations, violations, and TMF standards
- Risk-based monitoring and oversight frameworks
- Oracle Argus Safety workflows and navigation
- Advanced MedDRA: SOC, PT, LLT coding logic
- Causality and expectedness determination
- Narrative writing, case lock, and audit trail
- SAE definitions in trial context — regulatory standard
- 7-day and 15-day SAE reporting workflows
- SUSAR identification and competent authority submission
- DSMB/DMC safety review processes explained
- EDC fundamentals: design, data entry, queries
- CRF completion and data quality standards
- Source data verification and database lock
- Data flow from EDC to pharmacovigilance systems
- IND Safety Reports, MedWatch, FAERS (USFDA)
- EudraVigilance, SUSAR, EU CTR (EMA)
- ICH E2B(R3) electronic reporting structure
- CDSCO reporting and Indian PV Programme
- Site selection, qualification, and initiation
- Clinical monitoring visit types and SDV
- Monitoring report writing and finding classification
- Remote vs on-site monitoring under risk-based approach
- PRR, ROR, EBGM signal detection methods
- Signal triage, evaluation, and escalation
- Benefit-risk assessment across trial and post-market
- RMP structure and risk minimisation measures
- PBRER/PSUR structure — ICH E2C(R2)
- DSUR for clinical trials
- Benefit-risk language and aggregate narrative writing
- Submission timelines and data lock management
- IND, CTA, NDA/MAA safety sections
- Integrated summary of safety (ISS) structure
- Regional differences: FDA vs EMA vs CDSCO
- Post-approval commitments and Phase IV obligations
- Dual-domain career maps and role intersections
- Target employers: CROs, pharma MNCs, agencies
- Resume architecture for dual-qualified candidates
- Salary benchmarking for dual-domain professionals
- End-to-end ICSR processing simulation
- Clinical trial SAE to SUSAR scenario
- MedDRA coding challenge: complex cases
- 7-day regulatory timeline pressure simulation
- Comprehensive dual-domain written assessment
- Case study presentation with faculty review
- Career action plan: roles, applications, timeline
- Certification completion and professional profile review
What You Will Be Able to Do
By the end of this program, you will:
What Roles Can You Target After This Program?
PV Track Roles
- Drug Safety Specialist
- ICSR Processing Lead
- PV Compliance Analyst
- Signal Detection Analyst
- MedDRA Coding Lead
Clinical Research Roles
- Clinical Research Associate
- Clinical Data Manager
- Site Activation Specialist
- Trial Safety Coordinator
- Regulatory Submissions Associate
Dual-Domain & Senior
- Safety Operations Manager
- Pharmacovigilance CRA
- Clinical Safety Lead (CRO)
- Global Drug Safety Manager
- Dual-Domain Project Manager
Frequently Asked Questions
Because the market rewards people who can do both. Drug safety specialists who also understand clinical trial safety workflows are far more valuable to CROs — who operate across both. Dual-domain professionals are also more resilient to market shifts and consistently earn more than single-domain specialists.
GPA's dual program is built for depth, not breadth. By integrating the two disciplines rather than running them separately, you learn each domain in the context of the other — which accelerates genuine understanding. Week 13 simulation and Week 14 assessment ensure mastery, not just familiarity.
Yes, provided you have a science background and high motivation. The program starts with integrated foundations and builds progressively. Our faculty are experienced at calibrating to mixed-cohort groups.
Both — and that is the advantage. For CRO applications, lead with PV. For pharma sponsor roles, lead with clinical. For dual-domain positions (increasingly common in large CROs), present them as a unified skill set. Week 12 covers exactly how to position this on your resume and LinkedIn.
Dual-domain professionals in India with 1–3 years of experience typically earn 20–40% more than single-domain peers. Internationally — particularly in the GCC, UK, and Southeast Asia — dual certification is a significant competitive advantage for visa-sponsored positions.
Core content is self-paced, giving you flexibility around work and personal commitments. Live mentor sessions and simulation weeks have scheduled dates. Week 14 assessment has a defined submission window per batch. This structure balances flexibility with accountability.
Enroll in Advanced Dual Certification in Drug Safety & Clinical Research
Limited seats per batch. Industry-led. Certification upon completion.
admissions@globalpva-edu.com
globalpva-edu.com
Domestic Students (India)
₹39,999
International Students
$1,499
*Fees include examination & certification charges.